Home

Maravai LifeSciences Holdings, Inc. - Class A common stock (MRVI)

2.3450
+0.0450 (1.96%)

Maravai Lifesciences Holdings Inc is a biotechnology company that specializes in providing critical products and services for life sciences research and drug development

The company focuses on the supply of essential reagents and tools that support various applications, including mRNA production, immunotherapy, and cell and gene therapies. By offering a range of high-quality solutions, Maravai enables researchers and pharmaceutical companies to accelerate scientific discovery and the development of innovative therapies, playing a vital role in advancing public health and medicine.

SummaryNewsPress ReleasesChartHistoricalFAQ
MARAVAI LIFESCIENCES DEADLINE FOR LEADERSHIP is May 5, 2025 in a Securities Fraud Lawsuit Contact Kaplan Fox & Kilsheimer LLP
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · March 26, 2025
MARAVAI LIFESCIENCES DEADLINE FOR LEADERSHIP is May 5, 2025 in a Securities Fraud Lawsuit Contact Kaplan Fox & Kilsheimer LLP
NEW YORK - March 26, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) on behalf of investors that purchased or otherwise acquired Maravai securities between August 7, 2024 and February 24, 2025 (the “Class Period”).
Via TheNewswire.com · March 26, 2025
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRVI
NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
By Pomerantz LLP · Via GlobeNewswire · March 26, 2025
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Skyworks Solutions, Maravai, AppLovin, and Manhattan Associates and Encourages Investors to Contact the Firm
NEW YORK, March 25, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Skyworks Solutions, Inc. (NASDAQ:SWKS), Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), AppLovin Corporation (NASDAQ:APP), and Manhattan Associates, Inc. (NASDAQ:MANH). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · March 25, 2025
MRVI DEADLINE: Investors of Maravai LifeSciences Holdings, Inc. (MRVI) Are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on May 5, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · March 25, 2025
MRVI DEADLINE: Investors of Maravai LifeSciences Holdings, Inc. (MRVI) Are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on May 5, 2025
NEW YORK - March 25, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) on behalf of investors that purchased or otherwise acquired Maravai securities between August 7, 2024 and February 24, 2025 (the “Class Period”).
Via TheNewswire.com · March 25, 2025
MRVI Announcement: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against Maravai LifeSciences Holdings, Inc. (MRVI)
RADNOR, PA - March 24, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai”) (NASDAQ: MRVI) on behalf of those who purchased or otherwise acquired Maravai securities between August 7, 2024, and February 24, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is May 5, 2025.
Via TheNewswire.com · March 24, 2025
MRVI Announcement: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against Maravai LifeSciences Holdings, Inc. (MRVI)
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · March 24, 2025
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) and reminds investors of the May 5, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
By Faruqi & Faruqi, LLP · Via Business Wire · March 24, 2025
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Maravai LifeSciences To Contact Him Directly To Discuss Their Options
By Faruqi & Faruqi LLP · Via GlobeNewswire · March 23, 2025
MRVI Announcement: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against Maravai LifeSciences Holdings, Inc. (MRVI)
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · March 22, 2025
MRVI Announcement: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against Maravai LifeSciences Holdings, Inc. (MRVI)
RADNOR, PA - March 22, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai”) (NASDAQ: MRVI) on behalf of those who purchased or otherwise acquired Maravai securities between August 7, 2024, and February 24, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is May 5, 2025.
Via TheNewswire.com · March 22, 2025
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRVI
NEW YORK, March 21, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · March 21, 2025
Lowey Dannenberg Notifies Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm
NEW YORK, March 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) for violations of the federal securities laws on behalf of investors who purchased or acquired Maravai common stock between August 7, 2024 and February 24, 2025, inclusive (the “Class Period”).
By Lowey Dannenberg, P.C. · Via GlobeNewswire · March 21, 2025
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Skyworks Solutions, Maravai, and Manhattan Associates and Encourages Investors to Contact the Firm
NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Skyworks Solutions, Inc. (NASDAQ:SWKS), Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), and Manhattan Associates, Inc. (NASDAQ:MANH). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · March 20, 2025
Kessler Topaz Meltzer & Check, LLP Reminds MRVI Investors of May 5, 2025 Deadline in Securities Fraud Class Action and Urges Investors with Losses to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · March 20, 2025
Kessler Topaz Meltzer & Check, LLP Reminds MRVI Investors of May 5, 2025 Deadline in Securities Fraud Class Action and Urges Investors with Losses to Contact the Firm
RADNOR, PA - March 20, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai”) (NASDAQ: MRVI) on behalf of those who purchased or otherwise acquired Maravai securities between August 7, 2024, and February 24, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is May 5, 2025.
Via TheNewswire.com · March 20, 2025
Kirby McInerney LLP Reminds Maravai Lifesciences Holdings (MRVI) Investors of Securities Class Action
NEW YORK, March 19, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of California on behalf of those who acquired Maravai Lifesciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ:MRVI) securities during the period from August 7, 2024, through February 24, 2025 (“the Class Period”). Investors have until May 5, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.
By Kirby McInerney LLP · Via GlobeNewswire · March 19, 2025
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Maravai LifeSciences To Contact Him Directly To Discuss Their Options
By Faruqi & Faruqi LLP · Via GlobeNewswire · March 19, 2025
Maravai Lifesciences Reports Fourth Quarter and Full Year 2024 Financial Results
Schedules Conference Call for Thursday, March 20, 2025
MRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai” or “the Company”) (NASDAQ: MRVI) and certain of its officers.
Kessler Topaz Meltzer & Check, LLP Encourages Maravai LifeSciences Holdings, Inc. Investors with Losses to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · March 18, 2025
Kessler Topaz Meltzer & Check, LLP Encourages Maravai LifeSciences Holdings, Inc. Investors with Losses to Contact the Firm
RADNOR, PA - March 18, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com)  informs investors that a securities class action lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (“Maravai”) (NASDAQ: MRVI) on behalf of those who purchased or otherwise acquired Maravai securities between August 7, 2024, and February 24, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is May 5, 2025.
Via TheNewswire.com · March 18, 2025
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRVI
NEW YORK, March 17, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · March 17, 2025
Kaplan Fox Alerts Maravai LifeSciences Holdings, Inc. (MRVI) Investors to a Securities Class Action Lawsuit - Deadline is May 5, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · March 17, 2025